The circadian factor Period 2 modulates p53 stability and transcriptional activity in unstressed cells

Molecular Biology of the Cell

Volumn 25, Issue 19, 2014, Pages 3081-3093

  Gotoh, Tetsuya ^a   Vila Caballer, Marian ^a,b   Santos, Carlo S ^a,c   Liu, Jingjing ^a   Yang, Jianhua ^a,d   Finkielstein, Carla V ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PER2 PROTEIN; PROTEASOME; PROTEIN MDM2; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CIRCADIAN RHYTHM SIGNALING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; EXORIBONUCLEASE; GADD45A PROTEIN, HUMAN; MDM2 PROTEIN, HUMAN; MULTIPROTEIN COMPLEX; NUCLEAR PROTEIN; PER2 PROTEIN, HUMAN; PROTEIN 14 3 3; PROTEIN BINDING; SFN PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; ENVIRONMENTAL STRESS; GENOTOXICITY; HCT116 CELL LINE; HEK293 CELL LINE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TRANSCRIPTION INITIATION; UBIQUITINATION; BIOSYNTHESIS; DNA REPAIR; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

14-3-3 PROTEINS; BIOMARKERS, TUMOR; CELL CYCLE PROTEINS; CIRCADIAN CLOCKS; CIRCADIAN RHYTHM; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; DNA REPAIR; EXORIBONUCLEASES; GENE EXPRESSION REGULATION; HCT116 CELLS; HUMANS; MULTIPROTEIN COMPLEXES; NUCLEAR PROTEINS; PERIOD CIRCADIAN PROTEINS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MDM2; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION;

EID: 84917688278     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E14-05-0993     Document Type: Article

References (53)

1. Albrecht U, Bordon A, Schmutz I, Ripperger J (2007). The multiple facets of Per2. Cold Spring Harb Symp Quant Biol 72, 95-104.
2. Asher G, Shaul Y (2005). p53 proteasomal degradation: poly-ubiquitination is not the whole story. Cell Cycle 4, 1015-1018.
3. Ayed A, Mulder FA, Yi GS, Lu Y, Kay LE, Arrowsmith CH (2001). Latent and active p53 are identical in conformation. Nat Struct Biol 8, 756-760.
4. Barlev NA, Liu L, Chehab NH, Mansfield K, Harris KG, Halazonetis TD, Berger SL (2001). Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell 8, 1243-1254.
5. Bell-Pedersen D, Cassone VM, Earnest DJ, Golden SS, Hardin PE, Thomas TL, Zoran MJ (2005). Circadian rhythms from multiple oscillators: lessons from diverse organisms. Nat Rev Genet 6, 544-556.
6. Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, Kerkhoven RM, Madiredjo M, Nijkamp W, Weigelt B, et al. (2004). A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428, 431-437.
7. Bjarnason GA, Jordan RC, Sothern RB (1999). Circadian variation in the expression of cell-cycle proteins in human oral epithelium. Am J Pathol 154, 613-622.
8. Bjarnason GA, Jordan RC, Wood PA, Li Q, Lincoln DW, Sothern RB, Hrushesky WJ, Ben-David Y (2001). Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. Am J Pathol 158, 1793-1801.
9. Cajochen C, Jud C, Munch M, Kobialka S, Wirz-Justice A, Albrecht U (2006). Evening exposure to blue light stimulates the expression of the clock gene PER2 in humans. Eur J Neurosci 23, 1082-1086.
10. Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS, McKinney K, Tempst P, Prives C, Gamblin SJ, et al. (2004). Regulation of p53 activity through lysine methylation. Nature 432, 353-360.
11. Duffield GE (2003). DNA microarray analyses of circadian timing: the genomic basis of biological time. J Neuroendocrinol 15, 991-1002.
12. Duffield GE, Best JD, Meurers BH, Bittner A, Loros JJ, Dunlap JC (2002). Circadian programs of transcriptional activation, signaling, and protein turnover revealed by microarray analysis of mammalian cells. Curr Biol 12, 551-557.
13. Durgan DJ, Young ME (2010). The cardiomyocyte circadian clock: emerging roles in health and disease. Circ Res 106, 647-658.
14. Fu L, Pelicano H, Liu J, Huang P, Lee C (2002). The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111, 41-50.
15. Fukuhara C, Brewer JM, Dirden JC, Bittman EL, Tosini G, Harrington ME (2001). Neuropeptide Y rapidly reduces Period 1 and Period 2 mRNA levels in the hamster suprachiasmatic nucleus. Neurosci Lett 314, 119-122.
16. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler HP (2006). The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 22, 375-382.
17. Giannakakou P, Sackett DL, Ward Y, Webster KR, Blagosklonny MV, Fojo T (2000). p53 is associated with cellular microtubules and is transported to the nucleus by dynein. Nat Cell Biol 2, 709-717.
18. Griffin EA Jr, Staknis D, Weitz CJ (1999). Light-independent role of CRY1 and CRY2 in the mammalian circadian clock. Science 286, 768-771.
19. Harris SL, Levine AJ (2005). The p53 pathway: positive and negative feedback loops. Oncogene 24, 2899-2908.
20. Honda R, Tanaka H, Yasuda H (1997). Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420, 25-27.
21. Horikawa K, Yokota S, Fuji K, Akiyama M, Moriya T, Okamura H, Shibata S (2000). Nonphotic entrainment by 5-HT1A/7 receptor agonists accompanied by reduced Per1 and Per2 mRNA levels in the suprachiasmatic nuclei. J Neurosci 20, 5867-5873.
22. Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang C, Wang X, Wang Z, Cornelissen-Guillaume G, Halberg F (2006). Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci 97, 589-596.
23. Kim E, Rohaly G, Heinrichs S, Gimnopoulos D, Meissner H, Deppert W (1999). Influence of promoter DNA topology on sequence-specific DNA binding and transactivation by tumor suppressor p53. Oncogene 18, 7310-7318.
24. Ko CH, Takahashi JS (2006). Molecular components of the mammalian circadian clock. Hum Mol Genet 15(Spec No 2), R271-R277.
25. Kruse JP, Gu W (2009). Modes of p53 regulation. Cell 137, 609-622.
26. Kume K, Zylka MJ, Sriram S, Shearman LP, Weaver DR, Jin X, Maywood ES, Hastings MH, Reppert SM (1999). mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell 98, 193-205.
27. Lambert PF, Kashanchi F, Radonovich MF, Shiekhattar R, Brady JN (1998). Phosphorylation of p53 serine 15 increases interaction with CBP. J Biol Chem 273, 33048-33053.
28. Lamia KA, Storch KF, Weitz CJ (2008). Physiological significance of a peripheral tissue circadian clock. Proc Natl Acad Sci USA 105, 15172-15177.
29. Lavin MF, Gueven N (2006). The complexity of p53 stabilization and activation. Cell Death Differ 13, 941-950.
30. Li M, Brooks CL, Wu-Baer F, Chen D, Baer R, Gu W (2003). Mono-versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302, 1972-1975.
31. Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J, Gu W (2002). Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416, 648-653.
32. Lohrum MA, Ashcroft M, Kubbutat MH, Vousden KH (2000). Identification of a cryptic nucleolar-localization signal in MDM2. Nat Cell Biol 2, 179-181.
33. Lowrey PL, Takahashi JS (2004). Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu Rev Genomics Hum Genet 5, 407-441.
34. Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H (2003). Control mechanism of the circadian clock for timing of cell division in vivo. Science 302, 255-259.
35. Mertens I, Vandingenen A, Johnson EC, Shafer OT, Li W, Trigg JS, De Loof A, Schoofs L, Taghert PH (2005). PDF receptor signaling in Drosophila contributes to both circadian and geotactic behaviors. Neuron 48, 213-219.
36. Miki T, Matsumoto T, Zhao Z, Lee CC (2013). p53 regulates Period2 expression and the circadian clock. Nat Commun 4, 2444.
37. Miyazaki K, Mesaki M, Ishida N (2001). Nuclear entry mechanism of rat PER2 (rPER2): role of rPER2 in nuclear localization of CRY protein. Mol Cell Biol 21, 6651-6659.
38. Ohsaki K, Oishi K, Kozono Y, Nakayama K, Nakayama KI, Ishida N (2008). The role of β-TrCP1 and β-TrCP2 in circadian rhythm generation by mediating degradation of clock protein PER2. J Biochem 144, 609-618.
39. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, Schultz PG, Kay SA, Takahashi JS, Hogenesch JB (2002). Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 109, 307-320.
40. Peng Y, Chen L, Li C, Lu W, Chen J (2001). Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization. J Biol Chem 276, 40583-40590.
41. Schneider CA, Rasband WS, Eliceiri KW (2012). NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9, 671-675.
42. Schreiber E, Matthias P, Muller MM, Schaffner W (1989). Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res 17, 6419.
43. Segall LA, Perrin JS, Walker CD, Stewart J, Amir S (2006). Glucocorticoid rhythms control the rhythm of expression of the clock protein, Period2, in oval nucleus of the bed nucleus of the stria terminalis and central nucleus of the amygdala in rats. Neuroscience 140, 753-757.
44. Shi S, Hida A, McGuinness OP, Wasserman DH, Yamazaki S, Johnson CH (2010). Circadian clock gene Bmal1 is not essential; functional replacement with its paralog, Bmal2. Curr Biol 20, 316-321.
45. Storch KF, Lipan O, Leykin I, Viswanathan N, Davis FC, Wong WH, Weitz CJ (2002). Extensive and divergent circadian gene expression in liver and heart. Nature 417, 78-83.
46. Sun XX, Challagundla KB, Dai MS (2012). Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1. EMBO J 31, 576-592.
47. Takahashi JS, Hong HK, Ko CH, McDearmon EL (2008). The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet 9, 764-775.
48. Vielhaber EL, Duricka D, Ullman KS, Virshup DM (2001). Nuclear export of mammalian PERIOD proteins. J Biol Chem 276, 45921-45927.
49. Wesierska-Gadek J, Wojciechowski J, Schmid G (2003). Central and carboxy-terminal regions of human p53 protein are essential for interaction and complex formation with PARP-1. J Cell Biochem 89, 220-232.
50. Yang J, Kim KD, Lucas A, Drahos KE, Santos CS, Mury SP, Capelluto DG, Finkielstein CV (2008). A novel heme-regulatory motif mediates heme-dependent degradation of the circadian factor period 2. Mol Cell Biol 28, 4697-4711.
51. Yang X, Wood PA, Ansell CM, Ohmori M, Oh EY, Xiong Y, Berger FG, Pena MM, Hrushesky WJ (2009a). Beta-catenin induces beta-TrCP-mediated PER2 degradation altering circadian clock gene expression in intestinal mucosa of ApcMin/+ mice. J Biochem 145, 289-297.
52. Yang X, Wood PA, Oh EY, Du-Quiton J, Ansell CM, Hrushesky WJ (2009b). Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res Treat 117, 423-431.
53. Zhang EE, Liu AC, Hirota T, Miraglia LJ, Welch G, Pongsawakul PY, Liu X, Atwood A, Huss JW3rd, Janes J, et al. (2009). A genome-wide RNAi screen for modifiers of the circadian clock in human cells. Cell 139, 199-210.